Immix Biopharma Suspends Stock Offering Pending New Prospectus

Immix Biopharma, Inc. (IMMX) has released an update.

Immix Biopharma, Inc. has halted the offering of its common stock shares under a previously dated prospectus supplement, in connection with a Sales Agreement with ThinkEquity LLC. The company has indicated that no new stock sales will occur until a new prospectus supplement is filed. Despite this pause, their Sales Agreement remains valid, emphasizing that this announcement is not an attempt to sell or solicit securities sales.

For further insights into IMMX stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.